BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1902767)

  • 1. Orthoclone OKT3: an overview of the monoclonal antibody and the nursing considerations it presents.
    Pezze JL; Whiteman K
    Crit Care Nurse; 1991 May; 11(5):98-102, 104-7. PubMed ID: 1902767
    [No Abstract]   [Full Text] [Related]  

  • 2. Orthoclone OKT3 and cardiac transplantation: an overview.
    Mahon PM
    Crit Care Nurse; 1991 Sep; 11(8):42-7, 50. PubMed ID: 1909947
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic use of the monoclonal antibody Orthoclone OKT3.
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):1-58. PubMed ID: 3105133
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation.
    Goldstein G
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):1-6. PubMed ID: 3105134
    [No Abstract]   [Full Text] [Related]  

  • 5. Orthoclone OKT3 as rescue treatment for steroid-resistant and recurrent acute rejection in clinical renal transplantation.
    Tvedegaard E; Olgaard K
    Transplant Proc; 1990 Feb; 22(1):217-8. PubMed ID: 2106738
    [No Abstract]   [Full Text] [Related]  

  • 6. Orthoclone OKT3 as first-line therapy in acute renal allograft rejection.
    Strate M; Jørgensen KA; Rohr N; Elbirk A; Svendsen V; Birkeland SA
    Transplant Proc; 1990 Feb; 22(1):219-20. PubMed ID: 2106739
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection.
    Gilbert EM; Eiswirth CC; Renlund DG; Menlove RL; DeWitt CW; Freedman LA; Herrick CM; Gay WA; Bristow MR
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):45-53. PubMed ID: 3105140
    [No Abstract]   [Full Text] [Related]  

  • 8. Nursing implications of immunosuppression in transplantation.
    Shaefer M; Williams L
    Nurs Clin North Am; 1991 Jun; 26(2):291-314. PubMed ID: 1904575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversing cardiac transplant rejection with Orthoclone OKT3.
    Dault LA; Nagy CS; Collins JA
    Am J Nurs; 1989 Jul; 89(7):953-5. PubMed ID: 2500020
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.
    Macris MP; Frazier OH; Lammermeier D; Radovancevic B; Duncan JM
    J Heart Transplant; 1989; 8(4):281-7. PubMed ID: 2504894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthoclone OKT3 monoclonal antibody reversal of hepatic and cardiac allograft rejection unresponsive to conventional immunosuppressive treatments.
    Kremer AB; Barnes L; Hirsch RL; Goldstein G
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):54-7. PubMed ID: 3105141
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
    Monaco A; Goldstein G; Barnes L
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical development of Orthoclone OKT3.
    Cosimi AB
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):7-16. PubMed ID: 3105142
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation.
    Gordon RD; Tzakis AG; Iwatsuki S; Todo S; Esquivel CO; Marsh JW; Stieber A; Makowka L; Starzl TE
    Am J Kidney Dis; 1988 Feb; 11(2):141-4. PubMed ID: 3124609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of a patient with graft versus host reaction following allogenic bone marrow transplantation with the monoclonal antibody OKT3 (Orthoclone OKT3)].
    Jung G; Holler E; Kolb HJ; Wilmanns W
    Internist (Berl); 1989 Jun; 30(6):386-8. PubMed ID: 2503460
    [No Abstract]   [Full Text] [Related]  

  • 16. [Orthoclone OKT3 (Muromonab CD3)--the indications for and manner of its use. Side effects and their prevention].
    Filev A; Kumanov Kh; Slavov Ch; Tsvetkov M
    Khirurgiia (Sofiia); 1989; 42(6):80-2. PubMed ID: 2517512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction immunosuppression with OKT3 monoclonal antibody in cardiac transplant recipients.
    Pulpón LA; Domínguez P; Cháfer M; Segovia J; Crespo MG; Pradas G; Burgos R; Figuera D
    Transplant Proc; 1990 Oct; 22(5):2319. PubMed ID: 2120816
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody.
    McLigeyo SO; Notghi A; Anderton JL; Dick J
    East Afr Med J; 1990 Sep; 67(9):667-73. PubMed ID: 2123786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nursing care of patients receiving orthoclone OKT 3.
    Moir EJ
    ANNA J; 1989 Aug; 16(5):327-8, 366. PubMed ID: 2505696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic monitoring of Orthoclone OKT3-treated patients: the problem of antimonoclonal immune response.
    Bach JF; Chatenoud L
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):17-20. PubMed ID: 3105135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.